These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22211965)

  • 21. MicroRNA-29 in aortic dilation: implications for aneurysm formation.
    Boon RA; Seeger T; Heydt S; Fischer A; Hergenreider E; Horrevoets AJ; Vinciguerra M; Rosenthal N; Sciacca S; Pilato M; van Heijningen P; Essers J; Brandes RP; Zeiher AM; Dimmeler S
    Circ Res; 2011 Oct; 109(10):1115-9. PubMed ID: 21903938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the renin-angiotensin system in aortic aneurysmal diseases.
    Lu H; Rateri DL; Cassis LA; Daugherty A
    Curr Hypertens Rep; 2008 Apr; 10(2):99-106. PubMed ID: 18474175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural history of thoracic aortic aneurysms.
    Griepp RB; Ergin MA; Lansman SL; Galla JD; Pogo G
    Semin Thorac Cardiovasc Surg; 1991 Oct; 3(4):258-65. PubMed ID: 1793761
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin II-mediated development of vascular diseases.
    Daugherty A; Cassis L
    Trends Cardiovasc Med; 2004 Apr; 14(3):117-20. PubMed ID: 15121160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
    King VL; Trivedi DB; Gitlin JM; Loftin CD
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1137-43. PubMed ID: 16514081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms.
    Rateri DL; Davis FM; Balakrishnan A; Howatt DA; Moorleghen JJ; O'Connor WN; Charnigo R; Cassis LA; Daugherty A
    Am J Pathol; 2014 Sep; 184(9):2586-95. PubMed ID: 25038458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of genetic chromosomal loci for intracranial, thoracic aortic, and abdominal aortic aneurysms in search of common genetic risk factors.
    Ruigrok YM; Elias R; Wijmenga C; Rinkel GJ
    Cardiovasc Pathol; 2008; 17(1):40-7. PubMed ID: 18160059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
    Zhou Y; Chen R; Catanzaro SE; Hu L; Dansky HM; Catanzaro DF
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):486-92. PubMed ID: 15831357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms.
    Jones A; Deb R; Torsney E; Howe F; Dunkley M; Gnaneswaran Y; Gaze D; Nasr H; Loftus IM; Thompson MM; Cockerill GW
    Circulation; 2009 Jun; 119(24):3125-32. PubMed ID: 19506106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms.
    Tang PC; Coady MA; Lovoulos C; Dardik A; Aslan M; Elefteriades JA; Tellides G
    Circulation; 2005 Aug; 112(8):1098-105. PubMed ID: 16116068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A validated mouse model capable of recapitulating the protective effects of female sex hormones on ascending aortic aneurysms and dissections (AADs).
    Qi X; Wang F; Chun C; Saldarriaga L; Jiang Z; Pruitt EY; Arnaoutakis GJ; Upchurch GR; Jiang Z
    Physiol Rep; 2020 Nov; 8(22):e14631. PubMed ID: 33242364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice.
    Yamanouchi D; Morgan S; Kato K; Lengfeld J; Zhang F; Liu B
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):702-7. PubMed ID: 20075419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a new target in the renin-angiotensin system for aortic aneurysm therapy?
    Golledge J
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1456-7. PubMed ID: 23766385
    [No Abstract]   [Full Text] [Related]  

  • 35. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1999. A 17 1/2-year-old girl with a thoracoabdominal aneurysm.
    N Engl J Med; 1999 Feb; 340(8):635-41. PubMed ID: 10049073
    [No Abstract]   [Full Text] [Related]  

  • 36. Is losartan the true panacea for aneurysm disease? PRO.
    Collins MJ; Elefteriades JA
    Cardiol Clin; 2010 May; 28(2):273-7. PubMed ID: 20452541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular Mechanisms of Aortic Aneurysm Formation.
    Quintana RA; Taylor WR
    Circ Res; 2019 Feb; 124(4):607-618. PubMed ID: 30763207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of aortic aneurysm: insights from human genetics and mouse models.
    Wilson NK; Gould RA; Gallo MacFarlane E; Consortium ML
    Pharmacogenomics; 2016 Dec; 17(18):2071-2080. PubMed ID: 27922338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathobiology of idiopathic ascending aortic aneurysms.
    Kirsch EW; Radu NC; Allaire E; Loisance DY
    Asian Cardiovasc Thorac Ann; 2006 Jun; 14(3):254-60. PubMed ID: 16714709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses.
    Kurata A; Kawakami T; Sato J; Sakamoto A; Muramatsu T; Nakabayashi K
    Cardiovasc Pathol; 2011; 20(1):e1-7. PubMed ID: 20133169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.